Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/1995
09/20/1995EP0671927A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus
09/20/1995EP0671925A1 Therapeutic compounds derived from the neem tree
09/20/1995EP0671904A1 Antibiotic formulation and use for drug resistant infections
09/20/1995EP0671879A1 Prevention of retinal injury and degeneration by specific factors
09/20/1995EP0652972A4 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure.
09/20/1995EP0458965B1 Process for the preparation of vinyl ethers
09/20/1995EP0364559B1 Substituted adenine derivatives useful as therapeutic agents
09/20/1995CN1108655A 1,3-oxathiolane nucleoside analogues
09/20/1995CN1108649A Noel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them
09/20/1995CN1108648A Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them
09/20/1995CN1108575A Oil-based and water-based adjuvant mixture
09/20/1995CN1108529A Rapamycin formulations for oral administration
09/19/1995US5451518 Purified human ceramide-activated protein kinase
09/19/1995US5451499 Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof
09/19/1995US5451412 Biologically active undenatured whey protein concentrate as food supplement
09/19/1995US5451402 Method for killing yeast and sporular microorganisms with haloperoxidase-containing compositions
09/19/1995US5451400 Nucosal competitive exclusion flora
09/19/1995CA1337073C 4 amino quinolines and naphthyridines, process for their preparation and their use as medicines
09/19/1995CA1337045C Method for inhibiting the growth of salmonella
09/14/1995WO1995024490A1 Cell surface protein and effector cell bonding reagent
09/14/1995WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995WO1995024486A1 ANTIMICROBIAL PROTEINS FROM ARALIA AND $i(IMPATIENS)
09/14/1995WO1995024485A2 Coordinate in vivo gene expression
09/14/1995WO1995024475A1 Vaccine compositions
09/14/1995WO1995024470A1 Activating virus
09/14/1995WO1995024437A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
09/14/1995WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995WO1995024415A1 Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses
09/14/1995WO1995024408A1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
09/14/1995WO1995024398A1 Isoxazoline compounds as inhibitors of tnf release
09/14/1995WO1995024385A1 Sulphonamide derivatives as aspartyl protease inhibitors
09/14/1995WO1995024217A1 Methods for modulating t cell unresponsiveness
09/14/1995WO1995024214A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
09/14/1995WO1995024212A1 The use of interferon subtypes in the preparation of medicaments to treat viral infections
09/14/1995WO1995024209A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
09/14/1995WO1995024207A1 Composition for the treatment of lung disease
09/14/1995WO1995003406A3 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens
09/14/1995DE4407489A1 Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines Vaccine for the prevention of respiratory and reproductive diseases of the pig
09/14/1995CA2185229A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
09/14/1995CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995CA2185097A1 Activating virus
09/14/1995CA2185027A1 Methods for modulating t cell unresponsiveness
09/14/1995CA2184902A1 Vaccine compositions
09/14/1995CA2184833A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
09/14/1995CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995CA2184385A1 Composition for the treatment of lung disease
09/14/1995CA2183653A1 Sulphonamide derivatives as aspartyl protease inhibitors
09/14/1995CA2181354A1 Benzothiophene, benzofuran and indole-thiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
09/14/1995CA2180353A1 Antimicrobial proteins from aralia and impatiens
09/13/1995EP0671472A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody
09/13/1995EP0671409A2 Malonic acid derivatives having anti-adhesive properties
09/13/1995EP0671408A2 Carbohydrate mimetics having anti-adhesive properties
09/13/1995EP0671401A1 Beta lactames
09/13/1995EP0671391A1 5-Vinyl- and 5-ethinyl-quinolinone- and -naphthyridone-carboxylic acids
09/13/1995EP0671005A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
09/13/1995EP0670847A1 Subtilin variant of enhanced stability and activity
09/13/1995EP0670720A1 Enzyme inhibitors
09/13/1995EP0383770B1 Inhibition of eucaryotic pathogens and neoplasms with lytic peptides
09/13/1995CN1108261A New pseudopeptides having an antiviral action
09/13/1995CN1108259A New derivatives of erythromycin, their preparation process and their use as medicaments
09/13/1995CN1108138A Pharmaceutical using of bradykinin-antagonist in preparation of drug for treating viral illness
09/13/1995CN1029738C O-methyl derivatives of azithromycin, process and intermediate for their preparation, and use thereof in preparation of pharmaceuticals
09/12/1995US5449840 Viricides
09/12/1995US5449798 Phospholipid derivatives containing higher elements of the fifth group
09/12/1995US5449794 Benzopyran phenol derivatives for use as antibacterial agents
09/12/1995US5449782 Orally active antiviral compounds
09/12/1995US5449765 DNA encoding amino acids 590-710 of glycoprotein gII of pseudorabies virus
09/12/1995US5449752 Polypeptides with affinity to lipopolysaccharides and their uses
09/12/1995US5449685 Method and composition for treating HIV-type 1 infections
09/12/1995US5449684 Antitumor agents and viricides
09/12/1995US5449672 Bactericides
09/12/1995US5449608 Detection
09/12/1995US5449520 Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level
09/12/1995US5449355 Retrograde tissue splitter and method
09/12/1995CA2144390A1 Malonic acid derivatives having antiadhesive properties
09/12/1995CA2144388A1 Carbohydrate mimetics having antiadhesive properties
09/12/1995CA2144231A1 5-vinyl- and 5-ethinyl-quinolone- and -naphthyridone-carboxylic acids
09/12/1995CA2143519A1 Beta-lactams
09/08/1995WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/08/1995WO1995023866A1 Vector for liver-specific gene therapy
09/08/1995WO1995023862A1 Animals with targeted gene disruption
09/08/1995WO1995023848A1 Selective virus culture
09/08/1995WO1995023812A1 Antibiotic stalobacins
09/08/1995WO1995023808A1 3''-desmethoxy derivatives of erythromycin and azithromycin
09/08/1995WO1995023806A2 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
09/08/1995WO1995023797A1 Process for making an epoxide
09/08/1995WO1995023610A1 Pharmaceutical composition containing thymoctonan and azt
09/08/1995WO1995023607A1 Antibacterial agent containing tea extract or active fraction thereof and beta-lactam antibiotic
09/08/1995WO1995023605A1 Method for treating and inhibiting gastric and duodenal ulcers
09/08/1995WO1995023601A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
09/08/1995WO1995019429A3 Method and reagent for inhibiting hepatitis c virus replication
09/08/1995CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/08/1995CA2183951A1 Antibiotic stalobacins
09/08/1995CA2183329A1 Method for treating and inhibiting gastric and duodenal ulcers
09/08/1995CA2160250A1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
09/08/1995CA2160248A1 Pharmaceutical composition containing thymoctonan and azt
09/06/1995EP0670369A2 A novel peptide related to human programmed cell death and DNA encoding it
09/06/1995EP0670328A1 Therapeutic nucleosides
09/06/1995EP0670315A1 Triazole oxime derivatives having antimycotic acitivity
09/06/1995EP0670166A2 Formulations for orally administered pharmaceutical agents
1 ... 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 ... 1798